Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Net Margin (2018 - 2025)

Health Catalyst (HCAT) has disclosed Net Margin for 8 consecutive years, with 29.12% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 984.0% year-over-year to 29.12%, compared with a TTM value of 34.05% through Sep 2025, down 784.0%, and an annual FY2024 reading of 22.67%, up 1727.0% over the prior year.
  • Net Margin was 29.12% for Q3 2025 at Health Catalyst, up from 50.76% in the prior quarter.
  • Across five years, Net Margin topped out at 17.81% in Q2 2024 and bottomed at 75.7% in Q4 2021.
  • Average Net Margin over 5 years is 42.66%, with a median of 44.55% recorded in 2023.
  • The sharpest move saw Net Margin surged 3705bps in 2023, then tumbled -3296bps in 2025.
  • Year by year, Net Margin stood at 75.7% in 2021, then soared by 32bps to 51.74% in 2022, then grew by 22bps to 40.43% in 2023, then surged by 36bps to 25.97% in 2024, then decreased by -12bps to 29.12% in 2025.
  • Business Quant data shows Net Margin for HCAT at 29.12% in Q3 2025, 50.76% in Q2 2025, and 29.9% in Q1 2025.